NASCIMBENI, Fabio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.036
EU - Europa 2.248
AS - Asia 634
SA - Sud America 14
AF - Africa 10
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 3
Totale 8.953
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.020
GB - Regno Unito 764
IT - Italia 532
SE - Svezia 320
CN - Cina 230
DE - Germania 207
HK - Hong Kong 131
SG - Singapore 100
UA - Ucraina 89
FR - Francia 71
TR - Turchia 69
BG - Bulgaria 65
FI - Finlandia 62
IN - India 31
ID - Indonesia 20
LT - Lituania 20
BE - Belgio 19
RO - Romania 18
RU - Federazione Russa 17
VN - Vietnam 17
CA - Canada 13
CH - Svizzera 13
IE - Irlanda 11
BR - Brasile 8
CZ - Repubblica Ceca 8
ES - Italia 8
AU - Australia 7
MY - Malesia 7
KR - Corea 6
MK - Macedonia 6
NL - Olanda 6
IR - Iran 5
PH - Filippine 5
EG - Egitto 4
PE - Perù 3
PK - Pakistan 3
SI - Slovenia 3
TW - Taiwan 3
AT - Austria 2
BZ - Belize 2
EU - Europa 2
HR - Croazia 2
JP - Giappone 2
NG - Nigeria 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
BD - Bangladesh 1
BF - Burkina Faso 1
CL - Cile 1
CU - Cuba 1
DZ - Algeria 1
GH - Ghana 1
GR - Grecia 1
HU - Ungheria 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PL - Polonia 1
SA - Arabia Saudita 1
TH - Thailandia 1
VE - Venezuela 1
Totale 8.953
Salva come PNG Salva come JPEG
Città #
Fairfield 1.096
Southend 620
Woodbridge 557
Ashburn 505
Chandler 470
Seattle 440
Houston 434
Wilmington 397
Cambridge 347
Ann Arbor 317
Nyköping 269
Dearborn 236
Hong Kong 128
Jacksonville 117
Modena 102
San Diego 79
New York 75
Beijing 74
Singapore 67
Princeton 64
Sofia 63
Eugene 62
Izmir 53
Helsinki 44
Shanghai 29
London 28
Rome 27
Bremen 26
Redwood City 24
Fremont 22
Jakarta 20
Milan 20
Brussels 17
San Mateo 17
Dong Ket 16
Falls Church 15
Timisoara 15
Norwalk 14
Boardman 12
Palermo 12
Nanjing 11
Reggio Emilia 11
Abbiategrasso 9
Bologna 9
Kilburn 9
Parma 9
Chicago 8
Dublin 8
Hefei 8
Brno 7
Jinan 7
Padova 7
Verona 7
Augusta 6
Des Moines 6
Grafing 6
Guangzhou 6
Kunming 6
Messina 6
Munich 6
Naples 6
Paris 6
Toronto 6
Turin 6
Chiswick 5
Fuzhou 5
Hounslow 5
Phoenix 5
San Jose 5
Bari 4
Bobbio 4
Frankfurt am Main 4
Hebei 4
Lausanne 4
Leawood 4
Los Angeles 4
Monmouth Junction 4
Nanchang 4
Osimo 4
Philadelphia 4
Ravenna 4
Atessa 3
Basel 3
Brescia 3
Cagliari 3
Cepagatti 3
Fiesole 3
Florence 3
Lima 3
Montesilvano Marina 3
Mumbai 3
Nanning 3
Napoli 3
Seoul 3
Shenyang 3
São Paulo 3
Wuhan 3
Acton 2
Baotou 2
Belize City 2
Totale 7.233
Salva come PNG Salva come JPEG
Nome #
Terapia antialadosteronica e prevenzione della cardiomiopatia cirrotica 398
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN) 373
Spectrum of mutations in Italian patients with familial hypercholesterolemia: New results from the LIPIGEN study 216
Clinical features and natural history of cryptogenic cirrhosis compared to hepatitis C virus-related cirrhosis 211
Fatty liver is associated with an increased risk of diabetes and cardiovascular disease-Evidence from three different disease models: NAFLD, HCV and HIV 188
NAFLD as a Sexual Dimorphic Disease: Role of Gender and Reproductive Status in the Development and Progression of Nonalcoholic Fatty Liver Disease and Inherent Cardiovascular Risk 186
Drugs and acute porphyrias: reasons for a hazardous relationship 182
ANTIALDOSTERONE THERAPY IN LIVER CIRRHOSIS: A ROLE FOR PREVENTION OF CIRROTHIC CARDIOMIOPATHY? 181
Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis. 177
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 177
Do Nonalcoholic Fatty Liver Disease and Fetuin-A Play Different Roles in Symptomatic Coronary Artery Disease and Peripheral Arterial Disease? 176
Pathogenesis and significance of hepatitis C virus steatosis: An update on survival strategy of a successful pathogen 168
Nonalcoholic steatohepatitis heralding olmesartan-induced sprue-like enteropathy 167
Statins and nonalcoholic fatty liver disease in the era of precision medicine: More friends than foes 167
A critical appraisal of the use of ultrasound in hepatic steatosis 167
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis 164
Nonalcoholic fatty liver disease: Evolving paradigms 164
The time has come to look for metabolic dysfunction-associated fatty liver disease in adult patients with type 1 Gaucher disease 164
Cardiovascular risk, lipidemic phenotype and steatosis. A comparative analysis of cirrhotic and non-cirrhotic liver disease due to varying etiology. 162
Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease 162
Nonalcoholic fatty liver disease and COPD: is it time to cross the diaphragm? 154
From NAFLD in clinical practice to answers from guidelines. 152
Chronic hepatitis C virus infection and atherosclerosis: Clinical impact and mechanisms. 152
Energy balance, glucose and lipid metabolism, cardiovascular risk and liver disease burden in adult patients with type 1 Gaucher disease 150
Role of Multidrug-Resistance Protein 2 in coproporphyrin transport: results from experimental studies in bile fistula rat models 147
Antialdosterone therapy in liver cirrhosis: a role for prevention of cirrhitc cardiomiopathy ? 145
Type 2 diabetes in non-alcoholic fatty liver disease and hepatitis c virus infection—liver: The “Musketeer” in the spotlight 144
Hypothyroidism and nonalcoholic fatty liver disease - A chance association? 142
MTHFR C677T polymorhism and hyperhomocysteinemia in patients with liver cirrhosis complicated by portal vein thrombosis and hepatocellular carcinoma 138
Alcohol and Steatosis: The Japanese Paradox 138
Clinical, biochemical and genetic characteristics of Variegate Porphyria in Italy 135
Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases 133
A round trip from nonalcoholic fatty liver disease to diabetes: molecular targets to the rescue? 132
The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans 129
A "systems medicine" approach to the study of non-alcoholic fatty liver disease 126
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions 126
Insulin resistance in advanced liver cirrhosis : the role of liver dysfunction and the “dissociated” effect on glucose versus lipid and amino acid metabolism 124
Telomere shortening: An innocent bystander at the crossroad of NASH with ageing and cardiometabolic risk? 123
Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease 123
Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease 123
Association between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis 120
Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence? 118
Clinical relevance of liver histopathology and different histological classifications of NASH in adults 118
Performance and limitations of steatosis biomarkers in patients with nonalcoholic fatty liver disease 118
Inflammatory hepatocellular adenomatosis, metabolic syndrome, polycystic ovary syndrome and non-alcoholic steatohepatitis: Chance tetrad or association by necessity? 118
Do ultrasonographic semiquantitative indices predict histological changes in NASH irrespective of steatosis extent? 115
NAFLD, Hepatotropic Viruses, and Cardiometabolic Risk 115
Sex Differences in NAFLD: State of the Art and Identification of Research Gaps 114
Hyperferritinemia and diagnosis of type 1 Gaucher disease 110
Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications 109
Looking for women in hepatology: Sex authorship differences in clinical practice guidelines and position statements 107
Association of nonalcoholic fatty liver disease (Nafld) with peripheral diabetic polyneuropathy: A systematic review and meta-analysis 101
Is it time to include non-alcoholic fatty liver disease in the current risk scores for atrial fibrillation? 100
Non-alcoholic fatty liver disease: Diagnosis and investigation 99
Pathogenesis of hypothyroidism-induced NAFLD: Evidence for a distinct disease entity? 99
The genetic basis of Insulin resistance. A brief review 94
Synchronous cryptogenic liver cirrhosis and idiopathic pulmonary fibrosis: a clue to telomeres involvement on line pubblication 03-Oct-2012Hepatology- 91
The independent predictors of non-alcoholic steatohepatitis and its individual histological features.: Insulin resistance, serum uric acid, metabolic syndrome, alanine aminotransferase and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment 86
Hepatic and extrahepatic malignancies in NAFLD 85
Significant variations in elastometry measurements made within short-term in patients with chronic liver diseases 82
Liver involvement in Gaucher disease: A practical review for the hepatologist and the gastroenterologist 78
A case of statin-induced liver injury with positive rechallenge with a second statin. Is there a class effect? 71
Global multi-stakeholder endorsement of the MAFLD definition 55
Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomised trial in acute myocardial infarction 39
Lipoprotein(a) Genotype Influences the Clinical Diagnosis of Familial Hypercholesterolemia 19
Refinement of the diagnostic approach for the identification of children and adolescents affected by familial hypercholesterolemia: Evidence from the LIPIGEN study 16
Colon cancer in a 12-year-old girl with hypertriglyceridemia 6
Clinical Approach in the Management of Paediatric Patients with Familial Hypercholesterolemia: A National Survey Conducted by the LIPIGEN Paediatric Group 3
Totale 9.072
Salva come PNG Salva come JPEG
Categoria #
all - tutte 37.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.254
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.328 144 125 122 159 190 381 401 266 250 105 123 62
2020/20211.961 176 80 166 161 215 162 238 202 120 182 164 95
2021/20221.311 97 117 61 77 83 112 43 47 162 143 244 125
2022/20231.412 132 173 139 122 151 180 28 148 176 17 66 80
2023/2024846 34 54 81 71 164 76 59 85 22 22 58 120
2024/202555 55 0 0 0 0 0 0 0 0 0 0 0
Totale 9.072